EUVIMEDEUVIMED entdecken
Crossref

Novel Marker for Predicting Prognosis in Hepatitis B Virus-Associated Decompensated Cirrhosis: Monocyte-To-Albumin Ratio

ManChun Yuan, W eiLin Mao, Xia He, Qiu Zhang

Clinical Laboratory · 2023

DOI: 10.7754/clin.lab.2023.230204 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Laboratory, 2023. Verfasst von ManChun Yuan und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, End Stage Liver Disease, Hepatitis B. Die Arbeit wurde bisher 12-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B, ChronicEnd Stage Liver DiseaseHepatitis BHumansHepatitis B virusLiver CirrhosisRetrospective StudiesMonocytesSeverity of Illness IndexPrognosisAlbumins

Substanzen

Albumins

Zitieren

APA

Yuan, M., Mao, W. E., He, X., & Zhang, Q. (2023). Novel Marker for Predicting Prognosis in Hepatitis B Virus-Associated Decompensated Cirrhosis: Monocyte-To-Albumin Ratio. Clinical Laboratory. https://doi.org/10.7754/clin.lab.2023.230204

Vancouver

Yuan M, Mao WE, He X, Zhang Q. Novel Marker for Predicting Prognosis in Hepatitis B Virus-Associated Decompensated Cirrhosis: Monocyte-To-Albumin Ratio. Clinical Laboratory. 2023. doi:10.7754/clin.lab.2023.230204

BibTeX
@article{Yuan2023,
  author = {Yuan, ManChun and Mao, W eiLin and He, Xia and Zhang, Qiu},
  title = {Novel Marker for Predicting Prognosis in Hepatitis B Virus-Associated Decompensated Cirrhosis: Monocyte-To-Albumin Ratio},
  journal = {Clinical Laboratory},
  year = {2023},
  doi = {10.7754/clin.lab.2023.230204}
}
Kostenlos starten →